Why, When, and How Should We Provide Red Cell Transfusions and Erythropoiesis-Stimulating Agents to Support Red Cell Mass in Neonates?

Hematology, Immunology and Infectious Disease

Volumn , Issue , 2012, Pages 57-74

  Ohls, Robin K ^a,b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877583485     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2662-6.00005-5     Document Type: Chapter

References (99)

1. Bifano EM, Curran TR Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 1995, 22:657-669.
2. Maier RF, Obladen M, Muller-Hansen I, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002, 141:8-15.
3. Donato H, Vain N, Rendo P, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000, 105:1066-1072.
4. Ohls RK, Ehrenkranz RA, Das A, et al. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 2004, 114:1287-1291.
5. Widness JA, Seward VJ, Kromer IJ, et al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996, 129:680-687.
6. Maier RF, Sonntag J, Walka MM, et al. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr 2000, 136:220-224.
7. Lieberman JA, Weiskopf RB, Kelley SD, et al. Critical oxygen delivery in conscious humans is less than 7.3 mL O2 × kg(-1) × min(-1). Anesthesiology 2000, 92:407-413.
8. Madjdpour C, Spahn DR, Weiskopf RB Anemia and perioperative red blood cell transfusion: A matter of tolerance. Crit Care Med 2006, 34:S102-108.
9. Alverson DC The physiologic impact of anemia in the neonate. Clin Perinatol 1995, 22:609-625.
10. Willis C, Forman CS Chronic massive fetomaternal hemorrhage: a case report. Obstet Gynecol 1988, 71:459-461.
11. Inayat MS, Bernard AC, Gallicchio VS, et al. Oxygen carriers: a selected review. Transfus Apher Sci 2006, 34:25-32.
12. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003, 349:1236-1245.
13. Dodd RY Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003, 349:1205.
14. Alter HJ, Stamer SL, Dodd RY Emerging infectious diseases that threaten the blood supply. Semin Hematol 2007, 44:32-41.
15. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
16. Napolitano LM, Corwin HL Efficacy of red blood cell transfusion in the critically ill. Crit Care Clin 2004, 20:255-268.
17. Chant C, Wilson G, Friedrich JO Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care 2006, 10:R140.
18. Croce MA, Tolley EA, Claridge JA, Fabian TC Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 2005, 59:19-23.
19. Malone DL, Dunne J, Tracy JK, et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003, 54:898-905.
20. Goodman AM, Pollack MM, Patel KM, et al. Pediatric red blood cell transfusions increase resource use. J Pediatr 2003, 142:123-127.
21. Armano R, Gauvin F, Ducruet T, et al. Determinants of red blood cell transfusions in a pediatric critical care unit: a prospective, descriptive epidemiological study. Crit Care Med 2005, 33:2637-2644.
22. Nahum E, Ben-Ari J, Schonfeld T Blood transfusion policy among European pediatric intensive care physicians. J Intensive Care Med 2004, 19:38-43.
23. Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007, 356:1609-1619.
24. Shannon KM, Keith JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995, 95:1-8.
25. Red blood cell transfusions in newborn infants: Revised guidelines. Paediatr Child Health 2002, 7:553-566.
26. Kondro W Canadian Red Cross found negligent. Lancet 1997, 350:1154.
27. Bifano EM The effect of hematocrit (HCT) level on clinical outcomes in Extremely Low Birthweight (ELBW) infants. Pediatric Research 2001, 49:311A.
28. Bifano EM, Bode MM, D'Eugenio DB Prospective randomized trial of high vs. low hematocrit in Extremely Low Birth Weight (ELBW) infants: one year growth and neurodevelopmental outcome. Pediatric Research 2002, 51:325A.
29. Bell EF, Strauss RG, Widness JA Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005, 115:1685-1691.
30. Boedy RF, Mathew OP Letter to editor: Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005, 116:1048-1049.
31. Murray N, Roberts I, Stanworth S Letter to editor: Red blood cell transfusion in neonates. Pediatrics 2005, 116:1609.
32. Swamy RS, Embleton ND Letter to editor: Red blood cell transfusions in preterm infants: is there a difference between restrictive and liberal criteria?. Pediatrics 2005, 115:257-258.
33. McCoy TE, Conrad AL, Richman LC, Lindgren SD, Noupoulos PC, Bell EF Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol 2011, 17:347-367.
34. Nopoulos PC, Conrad AL, Bell EF, et al. Long-term Outcome of Brain Structure in Premature Infants: Effects of Liberal vs. Restricted Red Blood Cell Transfusions. Arch Pediatr Adolesc Med 2011 May, 165:443-450.
35. Kirpalani H, Whyte RK, Andersen C The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006, 149:301-307.
36. Whyte RK, Kirpalani H, Asztalos EV, et al. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics 2009 Jan, 123:207-213.
37. Wardle SP, Garr R, Yoxall CW, Weindling AM A pilot randomised controlled trial of peripheral fractional oxygen extraction to guide blood transfusions in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002, 86:F22-27.
38. Bifano EM, Smith F, Borer J Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia. J Pediatr 1992, 120:292-296.
39. Izraeli S, Ben-Sira L, Harell D, et al. Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of prematurity. J Pediatr 1993, 122:629-631.
40. Bard H, Fouron JC, Chessex P, Widness JA Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity in infants with bronchopulmonary dysplasia. J Pediatr 1998, 132:630-634.
41. Bohler T, Janecke A, Linderkamp O Blood transfusion in late anemia of prematurity: effect on oxygen consumption, heart rate, and weight gain in otherwise healthy infants. Infusionsther Transfusionsmed 1994, 21:376-679.
42. Alkalay AL, Galvis S, Ferry DA, et al. Hemodynamic changes in anemic premature infants: Are we allowing the hematocrits to fall too low?. Pediatrics 2003, 112:838-845.
43. Baer VL, Henry E, Lambert DK, et al. Implementing a program to improve compliance with neonatal intensive care unit transfusion guidelines was accompanied by a reduction in transfusion rate: a pre-post analysis within a multihospital health care system. Transfusion 2011, 51:264-269.
44. Weiskopf RB, Toy P, Hopf HW, et al. Acute isovolemic anemia impairs central processing as determined by P300 latency. Clin Neurophysiol 2005, 116:1028-1032.
45. Soul JS, Taylor GA, Wypij D, Duplessis AJ, et al. Noninvasive detection of changes in cerebral blood flow by near-infrared spectroscopy in a piglet model of hydrocephalus. Pediatr Res 2000, 48:445-449.
46. Dani C, Pratesi S, Fontanelli G, Barp J, Bertini G Blood transfusions increase cerebral, splanchnic, and renal oxygenation in anemic preterm infants. Transfusion 2010, 50:1220-1226. [Epub 2010 Jan 22.].
47. Bailey SM, Hendricks-Munoz KD, Wells JT, Mally P Packed red blood cell transfusion increases regional cerebral and splanchnic tissue oxygen saturation in anemic symptomatic preterm infants. Am J Perinatol 2010, 27:445-453. [Epub 2010 Jan 22].
48. Menke J, Voss U, Moller G, Jorch G Reproducibility of cerebral near infrared spectroscopy in neonates. Biol Neonate 2003, 83:6-11.
49. Morris KP, Naqvi N, Davies P, et al. A new formula for blood transfusion volume in the critically ill. Arch Dis Child 2005, 90:724-728.
50. Kling PJ, Schmidt RL, Roberts RA, et al. Serum erythropoietin levels during infancy: associations with erythropoiesis. J Pediatr 1996, 128:791-796.
51. Brown MS, Garcia JF, Phibbs RH, et al. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity. J Pediatr 1984, 105:793-798.
52. Stockman JA, Graeber JE, Clark DA, et al. Anemia of prematurity: Determinants of the erythropoietin response. J Pediatr 1984, 105:786-792.
53. Nadja H, Jens S, Francesco C, et al. Effects of a Combined Therapy of Erythropoietin, Iron, Folate, and Vitamin B12 on the Transfusion Requirements of Extremely Low Birth Weight Infants. Pediatrics 2006, 118:2004-2013.
54. Keyes WG, Donohue PK, Spivak JL, et al. Assessing the need for transfusion of premature infants and the role of hematocrit, clinical signs, and erythropoietin level. Pediatrics 1989, 84:412-417.
55. Bishara N, Ohls RK Current Controversies in the Management of Anemia of Prematurity. Seminars in Perinatology 2009, 33:29-34.
56. Ohls RK Human recombinant erythropoietin in prevention and treatment of anemia of prematurity. Paediatr Drugs 2002, 4:111-121.
57. Ohls RK Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. J Pediatr 2002, 140:3-6.
58. Ohlsson A, Aher SM Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006, 3. CD004863.
59. Liu PM, Fang PC, Huang CB, et al. 2005. Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g. Am J Perinatol 2005, 22:115-120.
60. Akkoyun I, Oto S, Yilmaz G, et al. Risk Factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006, 10:449-453.
61. Flynn JT, Bacalari E On supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes. J AAPOS 2000, 4:65-66.
62. Grimm C, Wenzel A, Acar N, Keller S, Seeliger M, Gassmann M Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration. Adv Exp Med Biol 2006, 588:119-131.
63. Becerra SP, Amaral J Erythropoietin-an endogenous retinal survival factor. N Engl J Med 2002, 347:1968-1970.
64. Fisher JW Erythropoietin: physiology and pharmacology update. Exp Biol Med 2003, 228:1-14.
65. DiBiasie A Evidence-based review of retinopathy of prematurity prevention in VLBW and ELBW infants. Neonatal Netw 2006, 25:393-403.
66. Patel S, Rowe MJ, Winters SA, McConaghy S, Ohls RK Elevated Erythropoietin mRNA and protein concentrations in the developing human eye. Pediatr Res 2008, 63:394-397.
67. Egrie JC, Browne JK Development and characterization of novel erythropoiesis stimulate protein (NESP). British J Cancer 2001, 84(Supplement 1):3-10.
68. Heatherington AC, Schuller J, Mercer AJ Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report. British J Cancer 2001, 84(Supplement 1):11-16.
69. Warwood TL, Ohls RK, Lambert DK, et al. Intravenous administration of Darbepoetin to NICU patients. J Perinatol 2006, 26:296-300.
70. Locatelli G, Olivares J, Walker R, et al. Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency. Kidney Intl 2001, 60:741-747.
71. Glaspy J, Jadeja JS, Justice G, et al. Darbepoetin alpha given every 1 or 2 weeks alleviates anemia associated with cancer chemotherapy. British J Cancer 2002, 87:268-276.
72. Allon M, Kleinman K, Walczyk M, et al. Pharmacokinetics and pharmacodynamics of Darbepoetin alpha and epoetin alpha in patients undergoing dialysis. Clin Pharmacol Ther 2002, 72:546-555.
73. Ohls RK, Dai A Long acting erythropoietin: clinical studies and potential uses in neonates. Clinics Perinatol 2004, 31:77-89.
74. Bennett CL, Luminari S, Nissenson AR, et al. Pure red-cell aplasia and epoetin therapy. N Engl J Med 2004 Sep 30, 351:1403-1408.
75. Carlini RG, Reyes AA, Rothstein M Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995, 47:740-745.
76. Shingo T, Sorokan ST, Shimazaki T, Weiss S Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 2001 Dec 15, 21:9733-9743.
77. Dame C, Bartmann P, Wolber E, Fahnenstich H, Hofmann D, Fandrey J Erythropoietin gene expression in different areas of the developing human central nervous system. Dev Brain Res 2000, 125:69-74.
78. Sirén A-L, Knerlich F, Poser W, Gleitner CH, Brück W, Ehrenreich H Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 2001, 101:271-276.
79. Chong ZZ, Kang J-Q, Maiese K Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt 1, Bad, and caspase-mediated pathways. British Journal of Pharmacology 2003, 138:1107-1118.
80. Wen TC, Sadamoto Y, Tanaka J, et al. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by upregulating Bcl-xL expression. J Neurosci Res 2002 Mar 15, 67(6):795-803.
81. Erbavraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A 2003 May 27, 100(11):6741-6746.
82. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, et al. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A 2002, 99:5627-5631.
83. Solaroglu I, Solaroglu A, Kaptanoglu E, Dede S, Haberal A, Beskonakli E, Kilinc K Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 2003 Jan, 19:19-22.
84. Sola A, Wen TC, Hamrick SE, Ferrero DM Potential for protection and repair following injury to the developing brain: a role for erythropoietin?. Pediatr Res 2005, 57:110R-117R.
85. Chang YS, Mu D, Wendland M, et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 2005, 58:106-111.
86. Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 2001, 98:4044-4049.
87. Blau J, Calo JM, Dozor D, Sutton M, Alpan G, La Gamma EF Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr 2011 Mar, 158(3):403. [Epub 2010 Nov 10].
88. Baer VL, Lambert DK, Henry E, Snow GL, Butler A, Christensen RD Among very-low-birth-weight neonates is red blood cell transfusion an independent risk factor for subsequently developing a severe intraventricular hemorrhage?. Transfusion 2011, 51:1170-1178.
89. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991, 77:930-936.
90. Williams GD, Bratton SL, Ramamoorthy C Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999, 89:57-64.
91. Kwiatkowski JL, Manno CS Blood transfusion support in pediatric cardiovascular surgery. Transfus Sci 1999, 21:63-72.
92. Mou SS, Giroir BP, Molitor-Kirsch EA, Leonard SR, et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med 2004, 351:1635-1644.
93. Lee TH, Reed W, Mangawang-Montalvo L, Watson J, Busch MP Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility. Transfusion 2001, 41:637-642.
94. Strauss RG, Burmeister LF, Johnson K, et al. Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 2000, 136:215-219.
95. Fernandes da Cunha DH, Nunes Dos Santos AM, Kopelman BI, et al. Transfusions of CPDA-1 red blood cells stored for up to 28 days decrease donor exposures in very low-birth-weight premature infants. Transfus Med 2005, 15:467-473.
96. Aladangady N, McHugh S, Aitchison TC, et al. Infant's blood volume in a controlled trial of placental transfusion at preterm delivery. Pediatrics 2006, 117:93-98.
97. Mercer JS, Vohr BR, McGrath MM, et al. Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics 2006, 117:1235-1242.
98. Chaparro CM, Neufeld LM, T Alavez G, et al. Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomized controlled trial. Lancet 2006, 367:1997-2004.
99. Philip A Delayed cord clamping in preterm infants. Pediatrics 2006, 117:1235-1242.